Antihypertensive therapy in elderly patients requires careful management of polypharmacy, frailty, and comorbidities to effectively reduce cardiovascular risks while minimizing adverse effects.
This review highlights the importance of considering frailty and psycho-social aspects when prescribing antihypertensive therapies to elderly patients to safely improve cardiovascular outcomes.
An extremely high blood vessel pressure, called hypertension, may result in myocardial infarction, cardiac arrest, stroke, and possibly death. The increase of obesity and a population that is older are contributing to the increasing global epidemic of hypertension. A third of the world's population is affected by hypertension. Related to age, adverse outcomes include arterial stiffness, cholinergic and neurohormonal dysregulation, changes in physiological blood flow, and decreased renal function. outlines recent antihypertensive guidelines applicable to older individuals, based on currently available data. The level of frailty and psycho-social aspects must be taken into account while developing management methods for hypertension in older persons. Diuretics, calcium channel blockers, and reninangiotensin system blockers used in antihypertensive therapy have all been proven to improve cardiovascular outcomes in elderly individuals. Younger generations must undergo lifestyle changes to prevent hypertension as they mature. In this review, I will discuss how the drug is prescribed safely to elderly patients and how its mechanism of action works to reduce hypertension and mitigate adverse effects in elderly patients.
Mishra et al. (Tue,) conducted a review in Hypertension. Antihypertensive therapy was evaluated. Antihypertensive therapy in elderly patients requires careful management of polypharmacy, frailty, and comorbidities to effectively reduce cardiovascular risks while minimizing adverse effects.